3020-OL:HK:HK-X DBMSCIUSA (HKD)

COMMON STOCK | Other |

Last Closing

USD 1385

Change

0.00 (0.00)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

There is no Profile data available for 3020-OL.HK.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-29 )

Largest Industry Peers for Other

Symbol Name Price(Change) Market Cap
1318:HK Mao Geping Cosmetics Co Ltd

N/A

USD 28.92B
0325:HK Bloks Group Ltd

N/A

USD 22.55B
1863:HK China Longevity Group Company ..

N/A

USD 1.17B
8355:HK I-CONTROL

N/A

USD 0.39B
8343:HK HongGuang Lighting Holdings Co..

N/A

USD 0.31B
0648:HK CHINA RENJ

N/A

USD 0.12B
0400-OL:HK COGOBUY

N/A

N/A
0272-OL:HK SHUI ON LAND

N/A

N/A
0419-OL:HK JIUHAO HEALTH

N/A

N/A
0287-OL:HK WINFAIR INV

N/A

N/A

ETFs Containing 3020-OL:HK

DXZ:CA Dynamic Active U.S. Mid-C.. 11.35 % 0.87 %

-0.11 (-0.16%)

CAD 0.03B
IHF iShares U.S. Healthcare P.. 10.39 % 0.43 %

-0.38 (-0.16%)

N/A
TETF 6.19 % 0.64 %

N/A

N/A
BGU:CA Bristol Gate Concentrated.. 5.18 % 0.85 %

-0.26 (-0.16%)

CAD 0.13B
BGU-U:CA Bristol Gate Concentrated.. 5.18 % 0.00 %

-0.03 (-0.16%)

CAD 0.11B
MID American Century Mid Cap .. 4.56 % 0.00 %

-0.72 (-0.16%)

USD 0.08B
LCG Sterling Capital Focus Eq.. 4.33 % 0.00 %

-0.47 (-0.16%)

USD 0.04B
IAI iShares U.S. Broker-Deale.. 4.32 % 0.42 %

-0.19 (-0.16%)

N/A
HDIV 2.83 % 0.00 %

N/A

N/A
PFUT Putnam Sustainable Future.. 1.73 % 0.00 %

-0.04 (-0.16%)

USD 0.32B
RYH 1.72 % 0.40 %

N/A

N/A
DSTL Distillate US Fundamental.. 1.64 % 0.00 %

N/A

USD 2.01B
HONR 1.20 % 0.65 %

N/A

N/A
IFSW:LSE iShares Edge MSCI World M.. 1.11 % 0.00 %

+0.04 (+-0.16%)

N/A
FSWD:LSE iShares Edge MSCI World M.. 1.11 % 0.00 %

+3.00 (+-0.16%)

N/A
IS07:F iShares IV Public Limited.. 1.11 % 0.00 %

+0.11 (+-0.16%)

N/A
IS07:XETRA iShares Edge MSCI World M.. 1.11 % 0.00 %

+0.03 (+-0.16%)

USD 0.01B
VVL:CA Vanguard Global Value Fac.. 0.63 % 0.40 %

+0.08 (+-0.16%)

N/A
SMD 0.45 % 0.10 %

N/A

N/A
ESGL ESGL Holdings Limited Ord.. 0.00 % 0.40 %

-0.01 (-0.16%)

USD 0.05B
JKH iShares Morningstar Mid-C.. 0.00 % 0.30 %

N/A

N/A
DRFU:CA Desjardins RI USA Multifa.. 0.00 % 0.57 %

+0.13 (+-0.16%)

CAD 5.97M
SPVM Invesco S&P 500 Value wit.. 0.00 % 0.39 %

-0.01 (-0.16%)

USD 0.09B
FHI-B:CA CI Health Care Giants Cov.. 0.00 % 0.00 %

N/A

CAD 0.05B
RYF 0.00 % 0.40 %

N/A

N/A
WBIF WBI BullBear Value 3000 E.. 0.00 % 1.05 %

-0.12 (-0.16%)

N/A
XXM:CA 0.00 % 0.68 %

N/A

N/A
IBCZ:F iShares IV Public Limited.. 0.00 % 0.00 %

N/A

N/A
IMCG iShares Morningstar Mid-C.. 0.00 % 0.00 %

-0.16 (-0.16%)

N/A
TDOC:CA TD Global Healthcare Lead.. 0.00 % 0.00 %

-0.09 (-0.16%)

CAD 0.09B

Market Performance

  Market Performance vs. Industry/Classification (Other) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.91% 73% C 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.91% 73% C 68% D+
Trailing 12 Months  
Capital Gain 23.44% 71% C- 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 23.44% 69% C- 70% C-
Trailing 5 Years  
Capital Gain 97.43% 81% B- 92% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 97.43% 81% B- 90% A-
Average Annual (5 Year Horizon)  
Capital Gain 17.30% 76% C+ 76% C+
Dividend Return 17.30% 74% C 75% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 20.15% 76% C+ 73% C
Risk Adjusted Return 85.86% 98% N/A 97% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (HKD)

Quarterly Financials (HKD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:

There is nothing we particularly dislike